Literature DB >> 6401326

Impact of development of the gastrointestinal tract on infant feeding.

E Lebenthal, P C Lee, L A Heitlinger.   

Abstract

We have described the developmental pattern of the gastrointestinal tract under optimal conditions (i.e., low risk pregnancy and normal labor and delivery at term). The tissues do not develop simultaneously, and morphologic and functional development are not concurrent. An important consideration is the effect of suboptimal or even adverse conditions on the developmental sequence and attainment of maturity. Malnutrition during both the prenatal and postnatal periods may restrict the morphologic and biochemical development of the gastrointestinal tract. Dietary modifications have been shown to alter the developmental pattern of intestinal and pancreatic enzymes in animal models. Drugs and hormonal therapy given during pregnancy and early infancy have been known to cause developmental defects, but the specific effects on the gastrointestinal tract have not been evaluated. For further understanding of digestibility of nutrients and absorption in the perinatal period, these departures from the normal development of the gastrointestinal tract and the mechanisms by which these potential effects occur remain to be described. In view of these undetermined factors, in the case of intolerance or unavailability of milk from the natural mother, feedings should be individualized, with attention to direct measurement of enzyme concentrations, balance studies, or both, especially in the case of extreme prematurity or unusual requirements.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401326     DOI: 10.1016/s0022-3476(83)80276-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Postnatal development of disaccharidase activities in jejunal fluid of preterm neonates.

Authors:  A J Mayne; G A Brown; D Sule; A S McNeish
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

2.  Role of salivary amylase in gastric and intestinal digestion of starch.

Authors:  E Lebenthal
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

Review 3.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 4.  Casein, a prohormone with an immunomodulating role for the newborn?

Authors:  D Migliore-Samour; P Jollès
Journal:  Experientia       Date:  1988-03-15

Review 5.  Drug dosage in children with reduced renal function.

Authors:  Markus Daschner
Journal:  Pediatr Nephrol       Date:  2005-08-23       Impact factor: 3.714

6.  Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.

Authors:  Angela Villiger; Cordula Stillhart; Neil Parrott; Martin Kuentz
Journal:  AAPS J       Date:  2016-04-08       Impact factor: 4.009

7.  Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction.

Authors:  H Schroten; F G Hanisch; R Plogmann; J Hacker; G Uhlenbruck; R Nobis-Bosch; V Wahn
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Infant feeding practices: 1984-85 versus 1977-78.

Authors:  P A Tanaka; D L Yeung; G H Anderson
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262

9.  Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds.

Authors:  Amit A Somani; Kirstin Thelen; Songmao Zheng; Mirjam N Trame; Katrin Coboeken; Michaela Meyer; Katrin Schnizler; Ibrahim Ince; Stefan Willmann; Stephan Schmidt
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics in infants and children. A reappraisal.

Authors:  G L Kearns; M D Reed
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.